Status:
TERMINATED
Effect of tDCS on Brain Organization and Motor Recovery
Lead Sponsor:
Adrian Guggisberg
Collaborating Sponsors:
University Hospital, Geneva
Clinique Romande de Readaptation
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Neurological deficits and motor disorders are extremely common after stroke. Physical therapies can improve the autonomy of these patients, but despite an intensive stationary neurorehabilitation, sev...
Eligibility Criteria
Inclusion
- Ischemic or hemorrhagic stroke
- ≤ 4 weeks after stroke onset
- Paresis of upper limb with Fugl-Meyer score between 15 and 55 at study entry
- Capable of participating during treatment sessions of 30-60 minutes
- Informed consent obtained
Exclusion
- Incapacity to understand study information or task instructions during trial.
- New additional stroke during rehabilitation
- Reduced vigilance or delirium
- Severe language deficits
- Preexisting affection of an upper limb
- Severe spasticity or dystonia
- Severe co-morbidities (e.g., traumatic, rheumatologic, neurodegenerative disease)
- Pregnancy
- Pacemaker
- Skull breach
- History of seizures or epilepsy
- Metallic object in the brain
- Other contraindication to non-invasive brain stimulation
Key Trial Info
Start Date :
November 13 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03342534
Start Date
November 13 2017
End Date
September 30 2024
Last Update
June 11 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Neurorehabilitation, University Hospital of Geneva
Geneva, Canton of Geneva, Switzerland, 1211
2
Universitäre Neurorehabilitation, Inselspital
Bern, Switzerland, 3010